
07.12.2011, 08:33
|
 |
Заслуженный участник
|
|
Регистрация: 10.04.2003
Город: Москва
Сообщений: 782
Поблагодарили 15 раз(а) за 15 сообщений
|
|
aVRT+ тоже плохо...
Цитата:
Anttila I, Nikus K, Nieminen T, Jula A, Salomaa V, Reunanen A, Nieminen MS, Lehtimäki T, Virtanen V, Kähönen M. Relation of Positive T Wave in Lead aVR to Risk of Cardiovascular Mortality. Am J Cardiol. 2011 Dec 15;108(12):1735-40. Epub 2011 Sep 8.
Source
Division of Internal Medicine, Department of Cardiology, Seinäjoki Central Hospital, Seinäjoki, Finland.
Abstract
We examined the prevalence and prognostic impact of a positive T wave in lead aVR (aVRT+) on a standard electrocardiogram in the general population. Data were collected from a large nationally representative (random sample) health examination survey conducted in Finland from 2000 through 2001. The survey consisted of 6,354 subjects (2,876 men and 3,478 women) ≥30 years who participated in the field health examination including standard electrocardiographic (ECG) recording at rest. The prevalence of aVRT+ (defined as positive or isoelectric T wave in lead aVR) was 2.2%. During the median follow-up of 98.5 months (interquartile range 96.6 to 99.6), there were 214 (3.5%) cardiovascular (CV) deaths. In Cox regression analysis after adjustment for age and gender, relative risks for CV and total mortalities associated with aVRT+ were 3.24 (95% confidence interval [CI] 2.32 to 4.54, p <0.001) and 1.91 (95% CI 1.47 to 2.49, p <0.001), respectively. In the fully adjusted model controlling for other risk factors, CV morbidity, and ECG findings, the relative risk for CV mortality for aVRT+ was 2.94 (95% CI 2.07 to 4.18, p <0.001). In conclusion, aVRT+, an easily recognized ECG finding, predicts risk for CV mortality in the general population. This finding could aid in screening for risk of total and CV mortalities.
|
|